Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL28417876

CO/N=C(/C(=O)O)c1ccco1.N

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
PTPN1 P18031 1/20 0.50
SMN1; SMN2 Q16637 7/20 0.49
TDP1 Q9NUW8 3/20 0.49
PKM P14618 3/20 0.44
ERCC5 P28715 1/20 0.44
FEN1 P39748 1/20 0.44
RAB9A P51151 5/20 0.43
NPC1 O15118 4/20 0.43
POLB P06746 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
THRB P10828 1/20 0.41
APEX1 P27695 1/20 0.41
RECQL P46063 1/20 0.41
MAOB P27338 2/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL5211578 1.00 CES2 (0.50) CES2CES1PTPN1SMN1; SMN2TDP1
Ammonia Solution, Strong SCHEMBL4752940 1.00 CES2 (0.50) CES2CES1PTPN1SMN1; SMN2TDP1
SCHEMBL2812477 0.98 CES2 (0.52) CES2CES1PTPN1SMN1; SMN2TDP1
SCHEMBL4609969 0.98 CES2 (0.52) CES2CES1PTPN1SMN1; SMN2TDP1
SCHEMBL11457463 0.98 CES2 (0.52) CES2CES1PTPN1SMN1; SMN2TDP1
SCHEMBL13983961 0.85 CES2 (0.52) CES2CES1PTPN1SMN1; SMN2TDP1
SCHEMBL5217865 0.83 CES2 (0.50) CES2CES1PTPN1SMN1; SMN2TDP1
SCHEMBL12180935 0.83 CES2 (0.50) CES2CES1PTPN1SMN1; SMN2TDP1
SCHEMBL9634783 0.83 CES2 (0.55) CES2CES1PTPN1SMN1; SMN2TDP1
SCHEMBL3729528 0.83 CES2 (0.50) CES2CES1PTPN1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109553629-B Preparation method of cefuroxime sodium intermediate E-type impurity compound 浙江永宁药业股份有限公司 2020-06-23 CN disclosed